Moderator
Vivian Lee, BSc, PharmD, The Chinese University of Hong Kong, Shatin, Hong Kong
Speakers
Orajitt Bumrungskulswat, Heart to Heart Foundation, Bangkok, Thailand; Jo A Watson, MPH, Pharmaceutical Benefits Advisory Committee, Canberra, Australia, Woden, Australia; Ti-Hwei How, MBA, ASK Health Asia, Singapore, Singapore
Access and affordability of high-impact healthcare innovations remain among the most pressing challenges facing the Asia-Pacific region. Across diverse healthcare systems, policymakers and stakeholders must address differing resource capacities, financing constraints, and healthcare priorities while ensuring patients can benefit from advances in medical innovation. This session will bring together patients, healthcare leaders, policymakers, researchers, and industry stakeholders to explore strategies for improving equitable access to healthcare innovation. Discussions will focus on balancing affordability with continued innovation, the evolving role of health economics and outcomes research, value assessment, real-world evidence, patient-centered decision-making, and sustainable healthcare financing to identify practical pathways forward.
Code
23b